Spis treści:
Spis załączników:
31_AGM_Resolutions.pdf (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
31_AGM_Resolutions.pdf (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 30 | / | 2025 | ||||||||
| Date of issue: | 2025-07-11 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| 31st Annual General Meeting resolutions of Krka, d. d., Novo mesto | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Pursuant to the provisions of the Rules of the Ljubljana Stock Exchange and Article 152 of the Market in Financial Instruments Act, the Management Board publishes the resolutions of the 31st Annual General Meeting of Shareholders. The adopted resolutions are attached. The notice will be published on the company's website (www.krka.biz) from 11 July 2025 onwards, for a minimum 5 years. |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 31 AGM Resolutions.pdf31 AGM Resolutions.pdf | 31st AGM Resolutions | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2025-07-11 | Jože Colarič | President of the Management Board and CEO | |||
Źródło:Komunikaty spółek (ESPI)
